Watch the Dallas Symposium LIVE, and fundraiser auction
Ticket proceeds support mindat.org! - click here...
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

(2021, November) Reactions Weekly Vol. 1881 (1) Springer Science and Business Media LLC

Advanced
   -   Only viewable:
Reference TypeJournal (issue)
JournalReactions WeeklyISSN0114-9954
Year2021 (November)Volume1881
Issue1
PublisherSpringer Science and Business Media LLC
Mindat Ref. ID13790508Long-form Identifiermindat:1:5:13790508:1
GUID0
Full Reference(2021, November) Reactions Weekly Vol. 1881 (1) Springer Science and Business Media LLC
Plain Text(2021, November) Reactions Weekly Vol. 1881 (1) Springer Science and Business Media LLC
In(2021) Reactions Weekly Vol. 1881. Springer Science and Business Media LLC

Contains

(2021) In utero exposure to NSAIDs may cause fetal disorders. Reactions Weekly, 1881 (1) 1 doi:10.1007/s40278-021-05210-2
(2021) Alcohol-based hand sanitisers may cause serious eye injuries. Reactions Weekly, 1881 (1) 2 doi:10.1007/s40278-021-05211-2
(2021) Dapagliflozin not to be used for type 1 diabetes mellitus. Reactions Weekly, 1881 (1) 4 doi:10.1007/s40278-021-05213-2
(2021) Benzodiazepines and related drugs may increase risk of dementia. Reactions Weekly, 1881 (1) 7 doi:10.1007/s40278-021-05216-2
(2021) DOACs plus antiplatelets may increase risk of intracranial haemorrhage. Reactions Weekly, 1881 (1) 9 doi:10.1007/s40278-021-05218-2
(2021) Increased risk of IV methotrexate AEs with concomitant febuxostat. Reactions Weekly, 1881 (1) 11 doi:10.1007/s40278-021-05220-1
(2021) No increase in birth defects after hydroxychloroquine during pregnancy. Reactions Weekly, 1881 (1) 12 doi:10.1007/s40278-021-05221-1
(2021) Other adverse reaction research. Reactions Weekly, 1881 (1) 13 doi:10.1007/s40278-021-05222-1
(2021) Abiraterone/denosumab/rosuvastatin. Reactions Weekly, 1881 (1) 14 doi:10.1007/s40278-021-05223-1
(2021) Acenocoumarol overdose. Reactions Weekly, 1881 (1) 15 doi:10.1007/s40278-021-05224-1
(2021) Ad26.cov2-s. Reactions Weekly, 1881 (1) 16 doi:10.1007/s40278-021-05225-1
(2021) Adalimumab. Reactions Weekly, 1881 (1) 17 doi:10.1007/s40278-021-05226-1
(2021) Adalimumab. Reactions Weekly, 1881 (1) 18 doi:10.1007/s40278-021-05227-1
(2021) Adefovir-dipivoxil. Reactions Weekly, 1881 (1) 19 doi:10.1007/s40278-021-05228-1
(2021) Agomelatine. Reactions Weekly, 1881 (1) 20 doi:10.1007/s40278-021-05229-1
(2021) Albumin-human/furosemide/tolvaptan. Reactions Weekly, 1881 (1) 21 doi:10.1007/s40278-021-05230-0
(2021) Amiodarone/carbimazole/warfarin. Reactions Weekly, 1881 (1) 22 doi:10.1007/s40278-021-05231-0
(2021) Antiarrhythmics. Reactions Weekly, 1881 (1) 23 doi:10.1007/s40278-021-05232-0
(2021) Antibacterials/hydrocortisone. Reactions Weekly, 1881 (1) 24 doi:10.1007/s40278-021-05233-0
(2021) Antineoplastics. Reactions Weekly, 1881 (1) 26 doi:10.1007/s40278-021-05235-0
(2021) Antituberculars. Reactions Weekly, 1881 (1) 30 doi:10.1007/s40278-021-05239-0
(2021) Antivirals. Reactions Weekly, 1881 (1) 31 doi:10.1007/s40278-021-05240-z
(2021) Apixaban. Reactions Weekly, 1881 (1) 32 doi:10.1007/s40278-021-05241-z
(2021) Aripiprazole/paliperidone/risperidone. Reactions Weekly, 1881 (1) 34 doi:10.1007/s40278-021-05243-z
(2021) Aspirin. Reactions Weekly, 1881 (1) 35 doi:10.1007/s40278-021-05244-z
(2021) Aspirin/atorvastatin/fenofibrate. Reactions Weekly, 1881 (1) 36 doi:10.1007/s40278-021-05245-z
(2021) Aspirin/clopidogrel/unspecified low molecular weight heparins. Reactions Weekly, 1881 (1) 37 doi:10.1007/s40278-021-05246-z
(2021) Aspirin/prasugrel/tirofiban. Reactions Weekly, 1881 (1) 38 doi:10.1007/s40278-021-05247-z
(2021) Atorvastatin. Reactions Weekly, 1881 (1) 39 doi:10.1007/s40278-021-05248-z
(2021) Azd-1222. Reactions Weekly, 1881 (1) 40 doi:10.1007/s40278-021-05249-z
(2021) Azd-1222. Reactions Weekly, 1881 (1) 41 doi:10.1007/s40278-021-05250-y
(2021) Azd-1222. Reactions Weekly, 1881 (1) 42 doi:10.1007/s40278-021-05251-y
(2021) AZD-1222. Reactions Weekly, 1881 (1) 43 doi:10.1007/s40278-021-05252-y
(2021) AZD-1222. Reactions Weekly, 1881 (1) 45 doi:10.1007/s40278-021-05254-y
(2021) AZD-1222. Reactions Weekly, 1881 (1) 46 doi:10.1007/s40278-021-05255-y
(2021) AZD-1222. Reactions Weekly, 1881 (1) 47 doi:10.1007/s40278-021-05256-y
(2021) AZD-1222/COVID-19-vaccine/COVID-19-Vaccine-Pfizer-BioNTech. Reactions Weekly, 1881 (1) 49 doi:10.1007/s40278-021-05258-y
(2021) Azithromycin. Reactions Weekly, 1881 (1) 50 doi:10.1007/s40278-021-05259-y
(2021) Bendamustine/dexamethasone/rituximab. Reactions Weekly, 1881 (1) 51 doi:10.1007/s40278-021-05260-x
(2021) Bevacizumab/ranibizumab. Reactions Weekly, 1881 (1) 52 doi:10.1007/s40278-021-05261-x
(2021) Bleomycin/cisplatin/etoposide. Reactions Weekly, 1881 (1) 53 doi:10.1007/s40278-021-05262-x
(2021) Bleomycin/cisplatin/etoposide. Reactions Weekly, 1881 (1) 54 doi:10.1007/s40278-021-05263-x
(2021) Bortezomib/carfilzomib/lenalidomide. Reactions Weekly, 1881 (1) 55 doi:10.1007/s40278-021-05264-x
(2021) Camrelizumab. Reactions Weekly, 1881 (1) 56 doi:10.1007/s40278-021-05265-x
(2021) Camrelizumab. Reactions Weekly, 1881 (1) 57 doi:10.1007/s40278-021-05266-x
(2021) Camrelizumab/carboplatin/pemetrexed. Reactions Weekly, 1881 (1) 58 doi:10.1007/s40278-021-05267-x
(2021) Camrelizumab/sorafenib. Reactions Weekly, 1881 (1) 59 doi:10.1007/s40278-021-05268-x
(2021) Captopril/furosemide/immune-globulin. Reactions Weekly, 1881 (1) 60 doi:10.1007/s40278-021-05269-x
(2021) Carbamazepine/colchicine interaction. Reactions Weekly, 1881 (1) 61 doi:10.1007/s40278-021-05270-9
(2021) Carboplatin. Reactions Weekly, 1881 (1) 62 doi:10.1007/s40278-021-05271-9
(2021) Carboplatin/fluorouracil/paclitaxel. Reactions Weekly, 1881 (1) 63 doi:10.1007/s40278-021-05272-9
(2021) Carboplatin/thiotepa. Reactions Weekly, 1881 (1) 64 doi:10.1007/s40278-021-05273-9
(2021) Carfilzomib. Reactions Weekly, 1881 (1) 65 doi:10.1007/s40278-021-05274-9
(2021) Ceftriaxone/meropenem/tobramycin. Reactions Weekly, 1881 (1) 68 doi:10.1007/s40278-021-05277-9
(2021) Ceftriaxone/metronidazole. Reactions Weekly, 1881 (1) 69 doi:10.1007/s40278-021-05278-9
(2021) Cemiplimab. Reactions Weekly, 1881 (1) 70 doi:10.1007/s40278-021-05279-9
(2021) Chorionic gonadotropin/letrozole/urofollitropin. Reactions Weekly, 1881 (1) 71 doi:10.1007/s40278-021-05280-8
(2021) Ciclosporin/meropenem/steroids. Reactions Weekly, 1881 (1) 72 doi:10.1007/s40278-021-05281-8
(2021) Ciclosporin/methotrexate/prednisolone. Reactions Weekly, 1881 (1) 73 doi:10.1007/s40278-021-05282-8
(2021) Cisplatin. Reactions Weekly, 1881 (1) 74 doi:10.1007/s40278-021-05283-8
(2021) Cisplatin/dexamethasone/netupitant/palonosetron. Reactions Weekly, 1881 (1) 75 doi:10.1007/s40278-021-05284-8
(2021) Cisplatin/gemcitabine. Reactions Weekly, 1881 (1) 76 doi:10.1007/s40278-021-05285-8
(2021) Cisplatin/ifosfamide/paclitaxel. Reactions Weekly, 1881 (1) 77 doi:10.1007/s40278-021-05286-8
(2021) Clarithromycin. Reactions Weekly, 1881 (1) 78 doi:10.1007/s40278-021-05287-8
(2021) Clindamycin/gentamicin. Reactions Weekly, 1881 (1) 79 doi:10.1007/s40278-021-05288-8
(2021) Clozapine. Reactions Weekly, 1881 (1) 80 doi:10.1007/s40278-021-05289-8
(2021) Colistimethate sodium/tigecycline. Reactions Weekly, 1881 (1) 81 doi:10.1007/s40278-021-05290-7
(2021) Corticosteroids/prednisone. Reactions Weekly, 1881 (1) 82 doi:10.1007/s40278-021-05291-7
(2021) Cyclophosphamide/eptacog-alfa withdrawal. Reactions Weekly, 1881 (1) 83 doi:10.1007/s40278-021-05292-7
(2021) Cyclophosphamide/fludarabine. Reactions Weekly, 1881 (1) 84 doi:10.1007/s40278-021-05293-7
(2021) Cytarabine. Reactions Weekly, 1881 (1) 85 doi:10.1007/s40278-021-05294-7
(2021) Dabigatran etexilate. Reactions Weekly, 1881 (1) 86 doi:10.1007/s40278-021-05295-7
(2021) Dabigatran etexilate. Reactions Weekly, 1881 (1) 87 doi:10.1007/s40278-021-05296-7
(2021) Dabrafenib. Reactions Weekly, 1881 (1) 88 doi:10.1007/s40278-021-05297-7
(2021) Dabrafenib/trametinib. Reactions Weekly, 1881 (1) 89 doi:10.1007/s40278-021-05298-7
(2021) Dapagliflozin. Reactions Weekly, 1881 (1) 90 doi:10.1007/s40278-021-05299-7
(2021) Dapagliflozin/empagliflozin. Reactions Weekly, 1881 (1) 91 doi:10.1007/s40278-021-05300-1
(2021) Dasatinib. Reactions Weekly, 1881 (1) 92 doi:10.1007/s40278-021-05301-1
(2021) Denosumab. Reactions Weekly, 1881 (1) 93 doi:10.1007/s40278-021-05302-1
(2021) Dexamethasone. Reactions Weekly, 1881 (1) 94 doi:10.1007/s40278-021-05303-1
(2021) Dexamethasone/insulin/ranibizumab. Reactions Weekly, 1881 (1) 95 doi:10.1007/s40278-021-05304-1
(2021) Dexmedetomidine/diazepam/olanzapine. Reactions Weekly, 1881 (1) 96 doi:10.1007/s40278-021-05305-1
(2021) Dienogest. Reactions Weekly, 1881 (1) 97 doi:10.1007/s40278-021-05306-1
(2021) Diethylstilbestrol. Reactions Weekly, 1881 (1) 98 doi:10.1007/s40278-021-05307-1
(2021) Digoxin. Reactions Weekly, 1881 (1) 99 doi:10.1007/s40278-021-05308-1
(2021) Diltiazem/immunosuppressants. Reactions Weekly, 1881 (1) 100 doi:10.1007/s40278-021-05309-1
(2021) Dimethyl fumarate/fingolimod. Reactions Weekly, 1881 (1) 101 doi:10.1007/s40278-021-05310-0
(2021) Doxazosin/ibuprofen. Reactions Weekly, 1881 (1) 103 doi:10.1007/s40278-021-05312-0
(2021) Doxycycline/ibuprofen. Reactions Weekly, 1881 (1) 104 doi:10.1007/s40278-021-05313-0
(2021) Duloxetine/linezolid/trazodone. Reactions Weekly, 1881 (1) 105 doi:10.1007/s40278-021-05314-0
(2021) Dupilumab. Reactions Weekly, 1881 (1) 106 doi:10.1007/s40278-021-05315-0
(2021) Dupilumab. Reactions Weekly, 1881 (1) 107 doi:10.1007/s40278-021-05316-0
(2021) Dupilumab. Reactions Weekly, 1881 (1) 108 doi:10.1007/s40278-021-05317-0
(2021) Empagliflozin. Reactions Weekly, 1881 (1) 109 doi:10.1007/s40278-021-05318-0
(2021) Emtricitabine/tenofovir disoproxil fumarate/tacrolimus. Reactions Weekly, 1881 (1) 110 doi:10.1007/s40278-021-05319-0
(2021) Enoxaparin sodium/mRNA-1273. Reactions Weekly, 1881 (1) 111 doi:10.1007/s40278-021-05320-z
(2021) Epinephrine. Reactions Weekly, 1881 (1) 112 doi:10.1007/s40278-021-05321-z
(2021) Epirubicin/ifosfamide. Reactions Weekly, 1881 (1) 113 doi:10.1007/s40278-021-05322-z
(2021) Eplerenone/losartan/metoprolol. Reactions Weekly, 1881 (1) 114 doi:10.1007/s40278-021-05323-z
(2021) Escitalopram/paroxetine. Reactions Weekly, 1881 (1) 115 doi:10.1007/s40278-021-05324-z
(2021) Esmolol. Reactions Weekly, 1881 (1) 116 doi:10.1007/s40278-021-05325-z
(2021) Etanercept/methotrexate/prednisolone. Reactions Weekly, 1881 (1) 117 doi:10.1007/s40278-021-05326-z
(2021) Ethinylestradiol/cyproterone. Reactions Weekly, 1881 (1) 118 doi:10.1007/s40278-021-05327-z
(2021) Etomidate. Reactions Weekly, 1881 (1) 119 doi:10.1007/s40278-021-05328-z
(2021) Etoposide/sodium-bicarbonate. Reactions Weekly, 1881 (1) 120 doi:10.1007/s40278-021-05329-z
(2021) Everolimus. Reactions Weekly, 1881 (1) 121 doi:10.1007/s40278-021-05330-y
(2021) Everolimus/sirolimus. Reactions Weekly, 1881 (1) 122 doi:10.1007/s40278-021-05331-y
(2021) Ferric carboxymaltose/prednisone. Reactions Weekly, 1881 (1) 123 doi:10.1007/s40278-021-05332-y
(2021) Gemcitabine/paclitaxel. Reactions Weekly, 1881 (1) 125 doi:10.1007/s40278-021-05334-y
(2021) Gentamicin. Reactions Weekly, 1881 (1) 126 doi:10.1007/s40278-021-05335-y
(2021) Gimeracil/oteracil/tegafur/nivolumab. Reactions Weekly, 1881 (1) 127 doi:10.1007/s40278-021-05336-y
(2021) Haloperidol/lorazepam/mrna-1273. Reactions Weekly, 1881 (1) 128 doi:10.1007/s40278-021-05337-y
(2021) Heparin. Reactions Weekly, 1881 (1) 129 doi:10.1007/s40278-021-05338-y
(2021) Heparin. Reactions Weekly, 1881 (1) 130 doi:10.1007/s40278-021-05339-y
(2021) Heparin. Reactions Weekly, 1881 (1) 131 doi:10.1007/s40278-021-05340-x
(2021) Heparin/rivaroxaban. Reactions Weekly, 1881 (1) 132 doi:10.1007/s40278-021-05341-x
(2021) HIV-protease-inhibitors. Reactions Weekly, 1881 (1) 133 doi:10.1007/s40278-021-05342-x
(2021) Hydrocortisone. Reactions Weekly, 1881 (1) 134 doi:10.1007/s40278-021-05343-x
(2021) Hydrocortisone. Reactions Weekly, 1881 (1) 135 doi:10.1007/s40278-021-05344-x
(2021) Hydromorphone. Reactions Weekly, 1881 (1) 136 doi:10.1007/s40278-021-05345-x
(2021) Hydroxychloroquine. Reactions Weekly, 1881 (1) 137 doi:10.1007/s40278-021-05346-x
(2021) Hydroxychloroquine. Reactions Weekly, 1881 (1) 138 doi:10.1007/s40278-021-05347-x
(2021) Idarubicin/tretinoin. Reactions Weekly, 1881 (1) 139 doi:10.1007/s40278-021-05348-x
(2021) Imatinib. Reactions Weekly, 1881 (1) 140 doi:10.1007/s40278-021-05349-x
(2021) Immunosuppresants. Reactions Weekly, 1881 (1) 141 doi:10.1007/s40278-021-05350-9
(2021) Immunosuppressants. Reactions Weekly, 1881 (1) 142 doi:10.1007/s40278-021-05351-9
(2021) Immunosuppressants. Reactions Weekly, 1881 (1) 143 doi:10.1007/s40278-021-05352-9
(2021) Immunosuppressants. Reactions Weekly, 1881 (1) 144 doi:10.1007/s40278-021-05353-9
(2021) Infliximab/methylprednisolone. Reactions Weekly, 1881 (1) 145 doi:10.1007/s40278-021-05354-9
(2021) Iodixanol. Reactions Weekly, 1881 (1) 146 doi:10.1007/s40278-021-05355-9
(2021) Ipilimumab/nivolumab. Reactions Weekly, 1881 (1) 147 doi:10.1007/s40278-021-05356-9
(2021) Ketamine. Reactions Weekly, 1881 (1) 148 doi:10.1007/s40278-021-05357-9
(2021) Lamotrigine/lorazepam/phenytoin. Reactions Weekly, 1881 (1) 149 doi:10.1007/s40278-021-05358-9
(2021) Lenalidomide. Reactions Weekly, 1881 (1) 150 doi:10.1007/s40278-021-05359-9
(2021) Levamisole abuse. Reactions Weekly, 1881 (1) 151 doi:10.1007/s40278-021-05360-8
(2021) Local anaesthetics/midazolam. Reactions Weekly, 1881 (1) 152 doi:10.1007/s40278-021-05361-8
(2021) Lutetium-(177lu)-oxodotreotide. Reactions Weekly, 1881 (1) 153 doi:10.1007/s40278-021-05362-8
(2021) Mesalazine/sulfasalazine. Reactions Weekly, 1881 (1) 154 doi:10.1007/s40278-021-05363-8
(2021) Metformin/olanzapine/paliperidone/pregabalin/risperidone. Reactions Weekly, 1881 (1) 155 doi:10.1007/s40278-021-05364-8
(2021) Methotrexate. Reactions Weekly, 1881 (1) 156 doi:10.1007/s40278-021-05365-8
(2021) Methotrexate/rituximab/tozinameran interaction. Reactions Weekly, 1881 (1) 158 doi:10.1007/s40278-021-05367-8
(2021) Methoxsalen. Reactions Weekly, 1881 (1) 159 doi:10.1007/s40278-021-05368-8
(2021) Methylprednisolone. Reactions Weekly, 1881 (1) 160 doi:10.1007/s40278-021-05369-8
(2021) Methylprednisolone. Reactions Weekly, 1881 (1) 161 doi:10.1007/s40278-021-05370-7
(2021) Methylprednisolone/nivolumab/prednisone. Reactions Weekly, 1881 (1) 163 doi:10.1007/s40278-021-05372-7
(2021) Methylprednisolone/plasma. Reactions Weekly, 1881 (1) 164 doi:10.1007/s40278-021-05373-7
(2021) Metronidazole. Reactions Weekly, 1881 (1) 165 doi:10.1007/s40278-021-05374-7
(2021) Minoxidil. Reactions Weekly, 1881 (1) 166 doi:10.1007/s40278-021-05375-7
(2021) Mometasone. Reactions Weekly, 1881 (1) 167 doi:10.1007/s40278-021-05376-7
(2021) mrna-1273. Reactions Weekly, 1881 (1) 169 doi:10.1007/s40278-021-05378-7
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 170 doi:10.1007/s40278-021-05379-7
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 171 doi:10.1007/s40278-021-05380-6
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 172 doi:10.1007/s40278-021-05381-6
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 173-174 doi:10.1007/s40278-021-05382-6
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 174 doi:10.1007/s40278-021-05383-6
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 175 doi:10.1007/s40278-021-05384-6
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 176 doi:10.1007/s40278-021-05385-6
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 177 doi:10.1007/s40278-021-05386-6
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 178 doi:10.1007/s40278-021-05387-6
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 179 doi:10.1007/s40278-021-05388-6
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 180 doi:10.1007/s40278-021-05389-6
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 181 doi:10.1007/s40278-021-05390-5
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 182 doi:10.1007/s40278-021-05391-5
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 183 doi:10.1007/s40278-021-05392-5
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 184 doi:10.1007/s40278-021-05393-5
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 185 doi:10.1007/s40278-021-05394-5
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 187 doi:10.1007/s40278-021-05396-5
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 189 doi:10.1007/s40278-021-05398-5
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 190 doi:10.1007/s40278-021-05399-5
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 191 doi:10.1007/s40278-021-05400-z
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 192 doi:10.1007/s40278-021-05401-z
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 193 doi:10.1007/s40278-021-05402-z
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 194 doi:10.1007/s40278-021-05403-z
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 195 doi:10.1007/s40278-021-05404-z
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 196 doi:10.1007/s40278-021-05405-z
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 197 doi:10.1007/s40278-021-05406-z
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 198 doi:10.1007/s40278-021-05407-z
(2021) Multiple drugs. Reactions Weekly, 1881 (1) 199 doi:10.1007/s40278-021-05408-z
(2021) Nifedipine/voriconazole interaction. Reactions Weekly, 1881 (1) 201 doi:10.1007/s40278-021-05410-y
(2021) Nivolumab. Reactions Weekly, 1881 (1) 202 doi:10.1007/s40278-021-05411-y
(2021) Nivolumab/pembrolizumab. Reactions Weekly, 1881 (1) 203 doi:10.1007/s40278-021-05412-y
(2021) Nivolumab/pembrolizumab. Reactions Weekly, 1881 (1) 204 doi:10.1007/s40278-021-05413-y
(2021) Nivolumab/tozinameran. Reactions Weekly, 1881 (1) 205 doi:10.1007/s40278-021-05414-y
(2021) Nonsteroidal-anti-inflammatories. Reactions Weekly, 1881 (1) 206 doi:10.1007/s40278-021-05415-y
(2021) Olanzapine. Reactions Weekly, 1881 (1) 207 doi:10.1007/s40278-021-05416-y
(2021) Olanzapine. Reactions Weekly, 1881 (1) 208 doi:10.1007/s40278-021-05417-y
(2021) Olaparib off label use. Reactions Weekly, 1881 (1) 209 doi:10.1007/s40278-021-05418-y
(2021) Omalizumab. Reactions Weekly, 1881 (1) 210 doi:10.1007/s40278-021-05419-y
(2021) Omeprazole/nivolumab. Reactions Weekly, 1881 (1) 211 doi:10.1007/s40278-021-05420-x
(2021) Oxycodone. Reactions Weekly, 1881 (1) 213 doi:10.1007/s40278-021-05422-x
(2021) Oxytocin. Reactions Weekly, 1881 (1) 214 doi:10.1007/s40278-021-05423-x
(2021) Pantoprazole. Reactions Weekly, 1881 (1) 215 doi:10.1007/s40278-021-05424-x
(2021) Parenteral-nutrition-supplements. Reactions Weekly, 1881 (1) 216 doi:10.1007/s40278-021-05425-x
(2021) Pembrolizumab. Reactions Weekly, 1881 (1) 217 doi:10.1007/s40278-021-05426-x
(2021) Pembrolizumab. Reactions Weekly, 1881 (1) 218 doi:10.1007/s40278-021-05427-x
(2021) Pembrolizumab. Reactions Weekly, 1881 (1) 219 doi:10.1007/s40278-021-05428-x
(2021) Piperacillin/tazobactam/vancomycin. Reactions Weekly, 1881 (1) 220 doi:10.1007/s40278-021-05429-x
(2021) Polycarbophil calcium. Reactions Weekly, 1881 (1) 221 doi:10.1007/s40278-021-05430-9
(2021) Prednisone. Reactions Weekly, 1881 (1) 222 doi:10.1007/s40278-021-05431-9
(2021) Pregabalin withdrawal. Reactions Weekly, 1881 (1) 223 doi:10.1007/s40278-021-05432-9
(2021) Propranolol. Reactions Weekly, 1881 (1) 224 doi:10.1007/s40278-021-05433-9
(2021) Quetiapine. Reactions Weekly, 1881 (1) 225 doi:10.1007/s40278-021-05434-9
(2021) Rabeprazole. Reactions Weekly, 1881 (1) 226 doi:10.1007/s40278-021-05435-9
(2021) Raloxifene. Reactions Weekly, 1881 (1) 227 doi:10.1007/s40278-021-05436-9
(2021) Remdesivir. Reactions Weekly, 1881 (1) 228 doi:10.1007/s40278-021-05437-9
(2021) Rituximab/unspecified steroids. Reactions Weekly, 1881 (1) 229 doi:10.1007/s40278-021-05438-9
(2021) Ropivacaine. Reactions Weekly, 1881 (1) 230 doi:10.1007/s40278-021-05439-9
(2021) Ruxolitinib. Reactions Weekly, 1881 (1) 231 doi:10.1007/s40278-021-05440-8
(2021) SARS COV-2 vaccine inactivated Sinovac Biotech. Reactions Weekly, 1881 (1) 232 doi:10.1007/s40278-021-05441-8
(2021) Sertraline. Reactions Weekly, 1881 (1) 233 doi:10.1007/s40278-021-05442-8
(2021) Sitagliptin. Reactions Weekly, 1881 (1) 234 doi:10.1007/s40278-021-05443-8
(2021) Tacrolimus. Reactions Weekly, 1881 (1) 236 doi:10.1007/s40278-021-05445-8
(2021) Tetryzoline overdose. Reactions Weekly, 1881 (1) 238 doi:10.1007/s40278-021-05447-8
(2021) Tigecycline. Reactions Weekly, 1881 (1) 239 doi:10.1007/s40278-021-05448-8
(2021) Tisagenlecleucel. Reactions Weekly, 1881 (1) 240 doi:10.1007/s40278-021-05449-8
(2021) Tisagenlecleucel. Reactions Weekly, 1881 (1) 241 doi:10.1007/s40278-021-05450-7
(2021) TJ-68. Reactions Weekly, 1881 (1) 242 doi:10.1007/s40278-021-05451-7
(2021) Tocilizumab. Reactions Weekly, 1881 (1) 243 doi:10.1007/s40278-021-05452-7
(2021) Tofacitinib. Reactions Weekly, 1881 (1) 244 doi:10.1007/s40278-021-05453-7
(2021) Tozinameran. Reactions Weekly, 1881 (1) 245 doi:10.1007/s40278-021-05454-7
(2021) Tozinameran. Reactions Weekly, 1881 (1) 246 doi:10.1007/s40278-021-05455-7
(2021) Tozinameran. Reactions Weekly, 1881 (1) 247 doi:10.1007/s40278-021-05456-7
(2021) Tozinameran. Reactions Weekly, 1881 (1) 248 doi:10.1007/s40278-021-05457-7
(2021) Trastuzumab-emtansine. Reactions Weekly, 1881 (1) 249 doi:10.1007/s40278-021-05458-7
(2021) Vancomycin. Reactions Weekly, 1881 (1) 251 doi:10.1007/s40278-021-05460-6
(2021) Vancomycin. Reactions Weekly, 1881 (1) 252 doi:10.1007/s40278-021-05461-6
(2021) Vandetanib. Reactions Weekly, 1881 (1) 253 doi:10.1007/s40278-021-05462-6
(2021) Vincristine. Reactions Weekly, 1881 (1) 254 doi:10.1007/s40278-021-05463-6
(2021) Warfarin. Reactions Weekly, 1881 (1) 256 doi:10.1007/s40278-021-05465-6
(2021) Zoledronic acid. Reactions Weekly, 1881 (1) 257 doi:10.1007/s40278-021-05466-6
(2021) Non-serious case reports. Reactions Weekly, 1881 (1) 258 doi:10.1007/s40278-021-05467-6

See Also

These are possibly similar items as determined by title/reference text matching only.

(2021, November) Reactions Weekly Vol. 1882 (1) Springer Science and Business Media LLC
(2021, November) Reactions Weekly Vol. 1880 (1) Springer Science and Business Media LLC
(2021, November) Reactions Weekly Vol. 1883 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1777 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1778 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1779 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1780 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1781 (1) Springer Science and Business Media LLC
(2016, November) Reactions Weekly Vol. 1626 (1) Springer Science and Business Media LLC
(2016, November) Reactions Weekly Vol. 1627 (1) Springer Science and Business Media LLC
(2016, November) Reactions Weekly Vol. 1628 (1) Springer Science and Business Media LLC
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are Β© OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: August 15, 2025 12:59:14
Go to top of page